☰

Roberta Pelanda - Publications

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology, Molecular Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Castleman MJ, Santos AL, Lesteberg KE, Maloney JP, Janssen WJ, Mould KJ, Beckham JD, Pelanda R, Torres RM. Activation and pro-inflammatory cytokine production by unswitched memory B cells during SARS-CoV-2 infection. Frontiers in Immunology. 14: 1213344. PMID 37638016 DOI: 10.3389/fimmu.2023.1213344  0.441
2023 Torres RM, Turner JA, D'Antonio M, Pelanda R, Kremer KN. Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid. Immunological Reviews. PMID 37096808 DOI: 10.1111/imr.13208  0.39
2023 McCaleb MR, Miranda AM, Ratliff KC, Torres RM, Pelanda R. CD19 Is Internalized Together with IgM in Proportion to B Cell Receptor Stimulation and Is Modulated by Phosphatidylinositol 3-Kinase in Bone Marrow Immature B Cells. Immunohorizons. 7: 49-63. PMID 36637517 DOI: 10.4049/immunohorizons.2200092  0.401
2022 Castleman MJ, Stumpf MM, Therrien NR, Smith MJ, Lesteberg KE, Palmer BE, Maloney JP, Janssen WJ, Mould KJ, Beckham JD, Pelanda R, Torres RM. Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells. Frontiers in Immunology. 13: 988125. PMID 36131937 DOI: 10.3389/fimmu.2022.988125  0.32
2022 Castleman MJ, Stumpf MM, Therrien NR, Smith MJ, Lesteberg KE, Palmer BE, Maloney JP, Janssen WJ, Mould KJ, Beckham JD, Pelanda R, Torres RM. SARS-CoV-2 infection relaxes peripheral B cell tolerance. The Journal of Experimental Medicine. 219. PMID 35420627 DOI: 10.1084/jem.20212553  0.485
2022 Kremer KN, Buser A, Thumkeo D, Narumiya S, Jacobelli J, Pelanda R, Torres RM. LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation. Proceedings of the National Academy of Sciences of the United States of America. 119: e2118816119. PMID 35394866 DOI: 10.1073/pnas.2118816119  0.366
2022 Pelanda R, Zikherman J. Many Achilles' heels of B and T cell tolerance. Immunological Reviews. PMID 35301733 DOI: 10.1111/imr.13076  0.507
2022 Peterson JN, Boackle SA, Taitano SH, Sang A, Lang J, Kelly M, Rahkola JT, Miranda AM, Sheridan RM, Thurman JM, Rao VK, Torres RM, Pelanda R. Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies. Frontiers in Immunology. 13: 795209. PMID 35185888 DOI: 10.3389/fimmu.2022.795209  0.674
2022 Pelanda R, Greaves SA, Alves da Costa T, Cedrone LM, Campbell ML, Torres RM. B-cell intrinsic and extrinsic signals that regulate central tolerance of mouse and human B cells. Immunological Reviews. PMID 34997597 DOI: 10.1111/imr.13062  0.6
2021 Alves da Costa T, Peterson JN, Lang J, Shulman J, Liang X, Freed BM, Boackle SA, Lauzurica P, Torres RM, Pelanda R. Central human B cell tolerance manifests with a distinctive cell phenotype and is enforced via CXCR4 signaling in hu-mice. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33850015 DOI: 10.1073/pnas.2021570118  0.562
2021 Zeng F, Chen Z, Chen R, Shufesky WJ, Bandyopadhyay M, Camirand G, Oberbarnscheidt MH, Sullivan MLG, Baty CJ, Yang MQ, Calderon M, Stolz DB, Erdos G, Pelanda R, Brennan TV, et al. Graft-derived extracellular vesicles transported across subcapsular sinus macrophages elicit B cell alloimmunity after transplantation. Science Translational Medicine. 13. PMID 33731430 DOI: 10.1126/scitranslmed.abb0122  0.423
2020 Agazio A, Cimons J, Shotts KM, Guo K, Santiago ML, Pelanda R, Torres RM. Histone H2A-Reactive B Cells Are Functionally Anergic in Healthy Mice With Potential to Provide Humoral Protection Against HIV-1. Frontiers in Immunology. 11: 1565. PMID 32849530 DOI: 10.3389/Fimmu.2020.01565  0.605
2020 Agazio A, Cimons J, Shotts KM, Guo K, Santiago ML, Pelanda R, Torres RM. Histone H2A-Reactive B Cells Are Functionally Anergic in Healthy Mice With Potential to Provide Humoral Protection Against HIV-1 Frontiers in Immunology. 11. DOI: 10.3389/fimmu.2020.01565  0.323
2019 Mathew D, Kremer KN, Strauch P, Tigyi G, Pelanda R, Torres RM. LPA Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling. Frontiers in Immunology. 10: 1159. PMID 31231367 DOI: 10.3389/Fimmu.2019.01159  0.464
2019 Greaves SA, Peterson JN, Strauch P, Torres RM, Pelanda R. Active PI3K abrogates central tolerance in high-avidity autoreactive B cells. The Journal of Experimental Medicine. PMID 30948496 DOI: 10.1084/Jem.20181652  0.72
2019 Capasso A, Lang J, Pitts TM, Jordan KR, Lieu CH, Davis SL, Diamond JR, Kopetz S, Barbee J, Peterson J, Freed BM, Yacob BW, Bagby SM, Messersmith WA, Slansky JE, ... Pelanda R, et al. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts. Journal For Immunotherapy of Cancer. 7: 37. PMID 30736857 DOI: 10.1186/S40425-019-0518-Z  0.322
2019 Mathew D, Strauch P, Pelanda R, Torres R. Abstract A202: Lysophosphatidic acid impedes the effector function of CD8+ T-cells through LPA5R Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A202  0.448
2018 Greaves SA, Peterson JN, Torres RM, Pelanda R. Corrigendum: Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance. Frontiers in Immunology. 9: 2218. PMID 30323810 DOI: 10.3389/Fimmu.2018.02218  0.574
2018 Sang A, Danhorn T, Peterson JN, Rankin AL, O'Connor BP, Leach SM, Torres RM, Pelanda R. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nature Communications. 9: 3973. PMID 30266981 DOI: 10.1038/S41467-018-06293-Z  0.739
2018 Hobeika E, Dautzenberg M, Levit-Zerdoun E, Pelanda R, Reth M. Conditional Selection of B Cells in Mice With an Inducible B Cell Development. Frontiers in Immunology. 9: 1806. PMID 30127788 DOI: 10.3389/Fimmu.2018.01806  0.729
2018 Agazio AE, Pelanda R, Torres RM. Silencing of TLM B cells by chronic HIV infection. Nature Immunology. 19: 902-903. PMID 30104630 DOI: 10.1038/S41590-018-0191-2  0.529
2018 Coleman CB, Lang J, Sweet LA, Smith NA, Freed BM, Pan Z, Haverkos B, Pelanda R, Rochford R. Epstein-Barr virus type-2 infects T-cells and induces B-cell lymphomagenesis in humanized mice. Journal of Virology. PMID 30089703 DOI: 10.1128/Jvi.00813-18  0.558
2018 Greaves SA, Peterson JN, Torres RM, Pelanda R. Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance. Frontiers in Immunology. 9: 707. PMID 29686680 DOI: 10.3389/Fimmu.2018.00707  0.719
2018 Bednarek J, Traxinger B, Brigham D, Roach J, Orlicky D, Wang D, Pelanda R, Mack CL. Cytokine-producing B cells promote immune-mediated bile duct injury in murine biliary atresia. Hepatology (Baltimore, Md.). PMID 29679373 DOI: 10.1002/Hep.30051  0.653
2018 Capasso A, Lang J, Pitts TM, Lieu CH, Kopetz S, Davis SL, Jordan K, Bagby SM, Messersmith WA, Pelanda R, Eckhardt SG. Abstract A012: Humanized patient-derived xenografts (PDXs) recapitulate clinical responses in microsatellite stable (MSS) and unstable (MSI-H) colorectal cancer (CRC) Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A012  0.312
2017 Lang J, Zhang B, Kelly M, Peterson JN, Barbee J, Freed BM, Di Santo JP, Matsuda JL, Torres RM, Pelanda R. Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice. Blood Advances. 1: 2729-2741. PMID 29296925 DOI: 10.1182/Bloodadvances.2017010090  0.631
2017 Capasso A, Lang J, Pitts TM, Francoeur P, Davis SL, Lieu CH, Bagby SM, Tentler JJ, Piscopio Ad, Diamond JR, Pelanda R, Eckhardt SG. HDAC and PD-1 inhibition in humanized triple-negative breast cancer xenografts. Journal of Clinical Oncology. 35: e14604-e14604. DOI: 10.1200/Jco.2017.35.15_Suppl.E14604  0.424
2016 Capasso A, Lang J, Pitts TM, Davis SL, Lieu CH, Bagby SM, Tan AC, Tentler JJ, Slansky JE, Pelanda R, Eckhardt SG. Abstract PR03: Characterizing the immune context of responses to immunotherapy in humanized patient derived xenograft models of CRC Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-Pr03  0.417
2015 Lang J, Ota T, Kelly M, Strauch P, Freed BM, Torres RM, Nemazee D, Pelanda R. Receptor editing and genetic variability in human autoreactive B cells. The Journal of Experimental Medicine. PMID 26694971 DOI: 10.1084/Jem.20151039  0.591
2015 Hobeika E, Levit-Zerdoun E, Anastasopoulou V, Pohlmeyer R, Altmeier S, Alsadeq A, Dobenecker MW, Pelanda R, Reth M. CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk. The Embo Journal. 34: 925-39. PMID 25630702 DOI: 10.15252/Embj.201489732  0.668
2014 Teodorovic LS, Babolin C, Rowland SL, Greaves SA, Baldwin DP, Torres RM, Pelanda R. Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies Proceedings of the National Academy of Sciences of the United States of America. 111: E2797-E2806. PMID 24958853 DOI: 10.1073/Pnas.1402159111  0.765
2014 Hu J, Oda SK, Shotts K, Donovan EE, Strauch P, Pujanauski LM, Victorino F, Al-Shami A, Fujiwara Y, Tigyi G, Oravecz T, Pelanda R, Torres RM. Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response. Journal of Immunology (Baltimore, Md. : 1950). 193: 85-95. PMID 24890721 DOI: 10.4049/Jimmunol.1300429  0.61
2014 Pelanda R. Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity? Current Opinion in Immunology. 27: 53-9. PMID 24549093 DOI: 10.1016/J.Coi.2014.01.012  0.697
2013 Oda SK, Strauch P, Fujiwara Y, Al-Shami A, Oravecz T, Tigyi G, Pelanda R, Torres RM. Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression. Cancer Immunology Research. 1: 245-55. PMID 24455753 DOI: 10.1158/2326-6066.Cir-13-0043-T  0.441
2013 Feldman AG, Tucker RM, Fenner EK, Pelanda R, Mack CL. B cell deficient mice are protected from biliary obstruction in the rotavirus-induced mouse model of biliary atresia. Plos One. 8: e73644. PMID 23991203 DOI: 10.1371/Journal.Pone.0073644  0.495
2013 Fuquay R, Renner B, Kulik L, McCullough JW, Amura C, Strassheim D, Pelanda R, Torres R, Thurman JM. Renal ischemia-reperfusion injury amplifies the humoral immune response. Journal of the American Society of Nephrology : Jasn. 24: 1063-72. PMID 23641055 DOI: 10.1681/Asn.2012060560  0.326
2013 Lang J, Kelly M, Freed BM, McCarter MD, Kedl RM, Torres RM, Pelanda R. Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. Journal of Immunology (Baltimore, Md. : 1950). 190: 2090-101. PMID 23335750 DOI: 10.4049/Jimmunol.1202810  0.649
2013 Pujanauski LM, Janoff EN, McCarter MD, Pelanda R, Torres RM. Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies. Proceedings of the National Academy of Sciences of the United States of America. 110: 1422-7. PMID 23288906 DOI: 10.1073/Pnas.1213713110  0.554
2013 Swanson CL, Pelanda R, Torres RM. Division of labor during primary humoral immunity. Immunologic Research. 55: 277-86. PMID 22945808 DOI: 10.1007/S12026-012-8372-9  0.639
2013 Rowland SL, Tuttle K, Torres RM, Pelanda R. Antigen and cytokine receptor signals guide the development of the naïve mature B cell repertoire Immunologic Research. 55: 231-240. PMID 22941591 DOI: 10.1007/S12026-012-8366-7  0.66
2012 Fournier EM, Velez MG, Leahy K, Swanson CL, Rubtsov AV, Torres RM, Pelanda R. Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice. The Journal of Experimental Medicine. 209: 1797-812. PMID 22927551 DOI: 10.1084/Jem.20120332  0.802
2012 Larson JD, Thurman JM, Rubtsov AV, Claypool D, Marrack P, van Dyk LF, Torres RM, Pelanda R. Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. 109: E1092-100. PMID 22474381 DOI: 10.1073/Pnas.1203019109  0.404
2012 Pelanda R, Torres RM. Central B-cell tolerance: where selection begins. Cold Spring Harbor Perspectives in Biology. 4: a007146. PMID 22378602 DOI: 10.1101/Cshperspect.A007146  0.67
2012 Teodorovic LS, Riccardi C, Torres RM, Pelanda R. Murine B cell development and antibody responses to model antigens are not impaired in the absence of the TNF receptor GITR. Plos One. 7: e31632. PMID 22328941 DOI: 10.1371/Journal.Pone.0031632  0.778
2011 Hartney JM, Gustafson CE, Bowler RP, Pelanda R, Torres RM. Thromboxane receptor signaling is required for fibronectin-induced matrix metalloproteinase 9 production by human and murine macrophages and is attenuated by the Arhgef1 molecule. The Journal of Biological Chemistry. 286: 44521-31. PMID 22086927 DOI: 10.1074/Jbc.M111.282772  0.374
2011 Eschbach C, Bach MP, Fidler I, Pelanda R, Köhler F, Rajewsky K, Jumaa H. Efficient generation of B lymphocytes by recognition of self-antigens. European Journal of Immunology. 41: 2397-403. PMID 21604259 DOI: 10.1002/Eji.201041344  0.643
2011 Lang J, Weiss N, Freed BM, Torres RM, Pelanda R. Generation of hematopoietic humanized mice in the newborn BALB/c-Rag2null Il2rγnull mouse model: a multivariable optimization approach. Clinical Immunology (Orlando, Fla.). 140: 102-16. PMID 21536497 DOI: 10.1016/J.Clim.2011.04.002  0.336
2011 Santiago ML, Smith DS, Barrett BS, Montano M, Benitez RL, Pelanda R, Hasenkrug KJ, Greene WC. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. Journal of Virology. 85: 189-99. PMID 20980520 DOI: 10.1128/Jvi.01838-10  0.529
2010 Rowland SL, Leahy KF, Halverson R, Torres RM, Pelanda R. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling Journal of Immunology. 185: 4570-4581. PMID 20861359 DOI: 10.4049/Jimmunol.1001708  0.699
2010 Swanson CL, Wilson TJ, Strauch P, Colonna M, Pelanda R, Torres RM. Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. The Journal of Experimental Medicine. 207: 1485-500. PMID 20566717 DOI: 10.1084/Jem.20092695  0.61
2010 Rowland SL, DePersis CL, Torres RM, Pelanda R. Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation Journal of Experimental Medicine. 207: 607-621. PMID 20176802 DOI: 10.1084/Jem.20091673  0.722
2010 Donovan EE, Pelanda R, Torres RM. S1P3 confers differential S1P-induced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development. European Journal of Immunology. 40: 688-98. PMID 20039302 DOI: 10.1002/Eji.200939858  0.642
2008 Pelanda R, Piccirillo CA. Tolerance, immune regulation, and autoimmunity: cells and cytokines that make a difference. Current Opinion in Immunology. 20: 629-31. PMID 18977298 DOI: 10.1016/J.Coi.2008.10.005  0.457
2008 Rubtsov AV, Swanson CL, Troy S, Strauch P, Pelanda R, Torres RM. TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. Journal of Immunology (Baltimore, Md. : 1950). 180: 3882-8. PMID 18322196 DOI: 10.4049/Jimmunol.180.6.3882  0.664
2008 Hu J, Strauch P, Rubtsov A, Donovan EE, Pelanda R, Torres RM. Lsc activity is controlled by oligomerization and regulates integrin adhesion. Molecular Immunology. 45: 1825-36. PMID 18157933 DOI: 10.1016/J.Molimm.2007.11.002  0.491
2008 Rowland S, Halverson R, Kane M, Torres R, Pelanda R. Contributions of Antigen and Cytokine Receptor Signals to Immature B cell Survival and Development The Faseb Journal. 22: 378-378. DOI: 10.1096/Fasebj.22.2_Supplement.378  0.617
2007 Velez MG, Kane M, Liu S, Gauld SB, Cambier JC, Torres RM, Pelanda R. Ig allotypic inclusion does not prevent B cell development or response. Journal of Immunology (Baltimore, Md. : 1950). 179: 1049-57. PMID 17617597 DOI: 10.4049/Jimmunol.179.2.1049  0.829
2007 Fraenkel S, Mostoslavsky R, Novobrantseva TI, Pelanda R, Chaudhuri J, Esposito G, Jung S, Alt FW, Rajewsky K, Cedar H, Bergman Y. Allelic 'choice' governs somatic hypermutation in vivo at the immunoglobulin kappa-chain locus. Nature Immunology. 8: 715-22. PMID 17546032 DOI: 10.1038/Ni1476  0.615
2007 Liu H, Schmidt-Supprian M, Shi Y, Hobeika E, Barteneva N, Jumaa H, Pelanda R, Reth M, Skok J, Rajewsky K. Yin Yang 1 is a critical regulator of B-cell development Genes and Development. 21: 1179-1189. PMID 17504937 DOI: 10.1101/Gad.1529307  0.532
2007 Brown JP, Taube C, Miyahara N, Koya T, Pelanda R, Gelfand EW, Torres RM. Arhgef1 is required by T cells for the development of airway hyperreactivity and inflammation. American Journal of Respiratory and Critical Care Medicine. 176: 10-9. PMID 17463415 DOI: 10.1164/Rccm.200702-270Oc  0.441
2006 Hobeika E, Thiemann S, Storch B, Jumaa H, Nielsen PJ, Pelanda R, Reth M. Testing gene function early in the B cell lineage in mb1-cre mice Proceedings of the National Academy of Sciences of the United States of America. 103: 13789-13794. PMID 16940357 DOI: 10.1073/Pnas.0605944103  0.661
2006 Sasaki Y, Derudder E, Hobeika E, Pelanda R, Reth M, Rajewsky K, Schmidt-Supprian M. Canonical NF-κB Activity, Dispensable for B Cell Development, Replaces BAFF-Receptor Signals and Promotes B Cell Proliferation upon Activation Immunity. 24: 729-739. PMID 16782029 DOI: 10.1016/J.Immuni.2006.04.005  0.621
2006 Pelanda R, Torres RM. Receptor editing for better or for worse. Current Opinion in Immunology. 18: 184-90. PMID 16460922 DOI: 10.1016/J.Coi.2006.01.005  0.608
2005 Rubtsov A, Strauch P, Digiacomo A, Hu J, Pelanda R, Torres RM. Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity. 23: 527-38. PMID 16286020 DOI: 10.1016/J.Immuni.2005.09.018  0.521
2005 Liu S, Velez MG, Humann J, Rowland S, Conrad FJ, Halverson R, Torres RM, Pelanda R. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. Journal of Immunology (Baltimore, Md. : 1950). 175: 5067-76. PMID 16210610 DOI: 10.4049/Jimmunol.175.8.5067  0.816
2005 Novobrantseva T, Xu S, Tan JE, Maruyama M, Schwers S, Pelanda R, Lam KP. Stochastic pairing of Ig heavy and light chains frequently generates B cell antigen receptors that are subject to editing in vivo. International Immunology. 17: 343-50. PMID 15710909 DOI: 10.1093/Intimm/Dxh214  0.616
2004 Galler GR, Mundt C, Parker M, Pelanda R, Mårtensson IL, Winkler TH. Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components. The Journal of Experimental Medicine. 199: 1523-32. PMID 15173209 DOI: 10.1084/Jem.20031523  0.626
2004 Halverson R, Torres RM, Pelanda R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nature Immunology. 5: 645-50. PMID 15156139 DOI: 10.1038/Ni1076  0.64
2004 Heinrich AC, Pelanda R, Klingmüller U. A mouse model for visualization and conditional mutations in the erythroid lineage. Blood. 104: 659-66. PMID 15090451 DOI: 10.1182/Blood-2003-05-1442  0.473
2004 Heinrich AC, Pelanda R, Klingmueller U. Manipulation and Visualization of the Erythroid Lineage - In Vivo Models for Erythroid Disorders. Blood. 104: 1620-1620. DOI: 10.1182/blood.v104.11.1620.1620  0.368
2002 Pelanda R, Braun U, Hobeika E, Nussenzweig MC, Reth M. B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-alpha and Ig-beta. Journal of Immunology (Baltimore, Md. : 1950). 169: 865-72. PMID 12097390 DOI: 10.4049/Jimmunol.169.2.865  0.517
2002 Pelanda R, Hobeika E, Kurokawa T, Zhang Y, Kuppig S, Reth M. Cre recombinase-controlled expression of the mb-1 allele. Genesis (New York, N.Y. : 2000). 32: 154-7. PMID 11857807 DOI: 10.1002/Gene.10070  0.575
2000 Braun U, Rajewsky K, Pelanda R. Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenes Proceedings of the National Academy of Sciences of the United States of America. 97: 7429-7434. PMID 10829061 DOI: 10.1073/Pnas.050578497  0.583
1999 Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 10: 451-61. PMID 10229188 DOI: 10.1016/S1074-7613(00)80045-X  0.536
1999 Novobrantseva TI, Martin VM, Pelanda R, Müller W, Rajewsky K, Ehlich A. Rearrangement and expression of immunoglobulin light chain genes can precede heavy chain expression during normal B cell development in mice Journal of Experimental Medicine. 189: 75-87. PMID 9874565 DOI: 10.1084/Jem.189.1.75  0.514
1998 Mostoslavsky R, Singh N, Kirillov A, Pelanda R, Cedar H, Chess A, Bergman Y. Kappa chain monoallelic demethylation and the establishment of allelic exclusion. Genes & Development. 12: 1801-11. PMID 9637682 DOI: 10.1101/Gad.12.12.1801  0.496
1998 Casellas R, Nussenzweig A, Wuerffel R, Pelanda R, Reichlin A, Suh H, Qin XF, Besmer E, Kenter A, Rajewsky K, Nussenzweig MC. Ku80 is required for immunoglobulin isotype switching Embo Journal. 17: 2404-2411. PMID 9545251 DOI: 10.1093/Emboj/17.8.2404  0.52
1997 Pelanda R, Schwers S, Sonoda E, Torres RM, Nemazee D, Rajewsky K. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity. 7: 765-75. PMID 9430222 DOI: 10.1016/S1074-7613(00)80395-7  0.659
1997 Papavasiliou F, Casellas R, Suh H, Qin XF, Besmer E, Pelanda R, Nemazee D, Rajewsky K, Nussenzweig MC. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science (New York, N.Y.). 278: 298-301. PMID 9323210 DOI: 10.1126/Science.278.5336.298  0.527
1996 Pelanda R, Schaal S, Torres RM, Rajewsky K. A prematurely expressed Igκ transgene, but not a VκJκ gene segment targeted into the Igκ locus, can rescue B cell development in λ5-deficient mice Immunity. 5: 229-239. PMID 8808678 DOI: 10.1016/S1074-7613(00)80318-0  0.49
Show low-probability matches.